Stay updated with breaking news from Developmental Therapeutics Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Industry veteran brings extensive clinical development experience to AVEO Oncology leadership team as Chief Medical Officer – – Formation of a Scientific Advisory Committee from...
Daniel Spratt, MD, discusses the integration of metastasis-directed therapy and hypofractionation in prostate cancer.
Amit Mahipal, MD, discusses data on camrelizumab plus rivoceranib in advanced hepatocellular carcinoma as well as the phase 3 CARES-310 trial, which is currently enrolling patients to receive the combination.
The family of a local boy who died from Osteosarcoma donated $6.4 million to the Children's Hospital of Philadelphia to advance research into rare cancer.
Daniel Spratt, MD, discusses research findings that have delineated the optimal sequencing of radiation therapy and hormone therapy for patients with prostate cancer.